Literature DB >> 641732

Ambiguities in IR and X-ray characterization of amphotericin B.

G Schwartzman, I Asher, V Folen, W Brannon, J Taylor.   

Abstract

Two distinct IR spectra of amphotericin B have been reported. These differences can be obtained from the same sample by surprisingly small changes in the method of sample preparation. Type I spectra (hand-ground samples) are characterized by a sharp C = O stretching band at 1692 cm-1, and Type II spectra (vibrator-ground samples) are characterized by a broad C = O stretching band near 1710 cm-1. X-ray powder diffraction demonstrates that vibrator grinding promotes a transition from a crystalline to an amorphous phase. The two phases are not bioequivalent. Differential thermal analysis reveals a transition near 157 degrees and samples heated to 158 degrees give only Type II IR spectra. However, a marked color change accompanies such heating (i.e., structural changes affecting the chromophore have been thermally induced), while X-ray spectra show an increase of only about 30% in amorphous content. Furthermore, hand-ground samples heated to 120 degrees still display only Type I IR spectra. Thus, the vibrator-induced transition is not solely a static thermal effect. Many observed spectral lines can be assigned to specific functional groups.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 641732     DOI: 10.1002/jps.2600670334

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  FTIR spectroscopic study of molecular organization of the antibiotic amphotericin B in aqueous solution and in DPPC lipid monolayers containing the sterols cholesterol and ergosterol.

Authors:  Mariusz Gagoś; Marta Arczewska
Journal:  Eur Biophys J       Date:  2012-07-26       Impact factor: 1.733

2.  Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.

Authors:  Alexan I Gomez; Maria F Acosta; Priya Muralidharan; Jason X-J Yuan; Stephen M Black; Don Hayes; Heidi M Mansour
Journal:  Pulm Pharmacol Ther       Date:  2020-10-31       Impact factor: 3.410

3.  Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.

Authors:  Qamar Zia; Owais Mohammad; Mohd Ahmar Rauf; Wasi Khan; Swaleha Zubair
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.